EXAS Stock: Path of Least Resistance The biotech stocks have failed to follow suit with the major market indices, and are underperforming, to say the least. I am finding it difficult to remember a time when the NASDAQ index was making new all-time highs and the biotech stocks were not participating. I have a slight inclination that is making me believe that this underperformance will not last. This inclination is the reason why I am focusing on EXACT Sciences Corporation (NASDAQ:EXAS) stock. I l...
EXAS Stock: Path of Least Resistance The biotech stocks have failed to follow suit with the major market indices, and are underperforming, to say the least. I am finding it difficult to remember a time when the NASDAQ index was making new all-time highs and the biotech stocks were not participating. I have a slight inclination that is making me believe that this underperformance will not last. This inclination is the reason why I am focusing on EXACT Sciences Corporation (NASDAQ:EXAS) stock. I l...
Share this Article
Recommended